Comparison
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868 vs 3q26q28 Deletion Syndrome C6010434
Clinical comparison between 46 XY Disorder OF Sex Development Due TO A Cholesterol Synthesis Defect and 3q26q28 Deletion Syndrome for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
A genetic condition impairing cholesterol synthesis, affecting sex hormone production. Typically part of Smith-Lemli-Opitz syndrome. Treatment focuses on cholesterol supplementation and hormone support.
3q26q28 Deletion Syndrome C6010434
A genetic condition involving deletion of part of chromosome 3q26q28, typically causing developmental delays, growth issues, and multiple congenital differences.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
0-0
3q26q28 Deletion Syndrome C6010434
Variable
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
severe
3q26q28 Deletion Syndrome C6010434
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
Chronic
3q26q28 Deletion Syndrome C6010434
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
No
3q26q28 Deletion Syndrome C6010434
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
reproductive
3q26q28 Deletion Syndrome C6010434
congenital
Same/different system
Category
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
metabolic
3q26q28 Deletion Syndrome C6010434
genetic
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-a-cholesterol-synthesis-defect-C5679868 and 3q26q28-deletion-syndrome-C6010434 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868 | 3q26q28 Deletion Syndrome C6010434 | Discriminating power |
|---|---|---|---|
| Genital development | 46,XY undervirilization linked to impaired sex-hormone synthesis. | Genital difference is not a defining feature in the supplied description. | High |
| Development | May occur in a broader syndrome; neurodevelopment is not fully specified here. | Developmental delay is a typical described feature. | Moderate |
| Growth and anomalies | Described as severe, but specific anomalies beyond sex development are not established. | Growth issues and multiple congenital differences are described. | Moderate |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868 when
46,XY infant with atypical genitalia and suspected sterol-pathway disorder
This matches the reproductive and metabolic concept supplied.
High
Specialist-confirmed abnormal cholesterol-pathway testing
Supports a synthesis defect rather than a chromosomal deletion.
Moderate
Clinical genetics review suggests Smith-Lemli-Opitz spectrum
The source states this DSD is typically part of that syndrome.
Moderate
Choose 3q26q28 Deletion Syndrome C6010434 when
Testing identifies a deletion involving 3q26q28
A confirmed deletion directly supports this syndrome.
High
Developmental delay, growth concerns, and congenital differences without a sterol diagnosis
This pattern aligns with the supplied phenotype.
Moderate
Microarray explains findings better than metabolic testing
The etiology is chromosomal rather than cholesterol synthesis.
Moderate
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868 | 3q26q28 Deletion Syndrome C6010434 | Interpretation |
|---|---|---|---|
| Sterol or cholesterol-pathway testing | May be abnormal; no cutoff is supplied. | Not the defining test for the deletion. | An abnormal result requires specialist confirmation and is not a complete diagnosis alone. |
| Chromosomal microarray or karyotype | No 3q26q28 deletion is required by this concept. | Deletion of 3q26q28 supports the syndrome. | The laboratory report must be correlated with clinical findings. |
| Karyotype and endocrine evaluation | 46,XY with possible impaired sex-hormone production. | Sex chromosomes are not the defining abnormality. | Hormone results need clinician interpretation; no thresholds are provided. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To A Cholesterol Synthesis Defect C5679868
- Outcome
- Chronic and potentially severe; exact outcome is not established.
- Factors
- Confirmed sterol defect, syndrome features, endocrine needs, and organ involvement.
3q26q28 Deletion Syndrome C6010434
- Outcome
- Chronic and generally described as moderate, with variable expression.
- Factors
- Deletion extent, development, growth, and congenital differences.
Time frame: Lifelong from congenital or early presentation; course cannot be precisely predicted.
Accurate diagnosis, supportive care, and monitoring of development and associated anomalies.
Complications comparison
| Complication | Presentation |
|---|---|
| Endocrine and reproductive effects | Possible hormone deficiency and atypical genital development. Not specifically established by the supplied description. Care is individualized; no treatment dose is stated. |
| Neurodevelopment | May be affected in the broader syndrome, but extent is not quantified. Developmental delay is a typical described feature. Early developmental assessment is appropriate after confirmation. |
| Growth and congenital differences | A severe course is possible, but specific complications are not listed. Growth issues and multiple congenital differences are described. Monitoring depends on confirmed findings and involved organs. |
Patient education highlights
- HighConfirming the diagnosis
These conditions have different genetic mechanisms. Test results should be explained by a clinician or genetic specialist.
- HighTreatment limits
The cholesterol-synthesis condition may need cholesterol or hormone support, but no dose or regimen is established here.
- MediumCounseling and support
Genetic counseling can discuss recurrence and resources without predicting an exact individual outcome.